![]() Establishing a standard definition for child overweight and obesity worldwide: international survey. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes. EXG-Gated Multiecho Dixon Fat-Wather Separation in Cardiac MRI: Advantages Over Conventional Fat-Saturated Imaging. Atherosclerosis 2006 189: 236-40.įarrelly C, Shah S, Amir D, Aoife N. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Krzyanowska W, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, et al. The relationship between plasma asymmetrical dimethyl-l-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Hokanson JE, Brunzell JD. Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B, Nathan DM DCCT/EDIC Research Group Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population, Diabetic Med, 2014 31:581–5 Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN). Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus The Steno Type 1 Risk Engine. Vistisen D, Andersen S, Stevns Hansen C, et al. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Miller R, Secrest A, Sharma R, Songer T, Orchard T. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Moreno P, Murcia A, Palacios I, Leon M, Bernardi V, Fuster V, et al. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association. Int J Obes (Lond) 2009 33:796–805įerranti SD, Boer IH, Fonseca V, et al. Adiposity and mortality in type 1 diabetes. ![]() IDF International Diabetes Federation, Diabetes Atlas 2017: ISBN: 978-2-93Ĭonway B, Miller RG, Costacou T, et al. The aim of this article is to present the design of the study of the cardiovascular and metabolic risk in patients with long-term T1DM. Prioritization of cost-effective projects and specific timely commitment to protect disability in these patients is of utmost importance in scientific and healthcare aspects. With prevalence of intensified insulin therapy in T1DM, leading sometimes to relatively high doses, and with the contemporary habits of eating, the patients’ risk of morbidity and mortality increases. Lack of established practices and algorithms for management in these individuals has been poorly studied and presented to date. Obesity is a progressing risk factor and its role in the cardiovascular pathology of patients with T1DM is unclear. The increasing knowledge of the role of inflammation and visceral adipose tissue in the pathogenesis of T1DM complications is an integral part of the work of leading European centers. Among the traditional risk factors for cardiovascular diseases (CVD) in individuals with type 1 diabetes mellitus (T1DM), new ones are constantly being sought for timely prophylaxis and treatment.
0 Comments
Leave a Reply. |